Kathy Abbott-Banner
4PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 09, 2024
Randomized, placebo-controlled study on the effects of intravenous GSK3858279 (anti-CCL17) on a battery of evoked pain tests in healthy participants.Yvonne Boyle, Hemme J Hijma, Jamie Rees
|Jan 06, 2022
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology.Debra Tompson, Mark Whitaker, Rennan Pan
|Aug 14, 2021
A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis.Kathy Weisel, Nicola Scott, Scott Berger
|Jun 17, 2021
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772.Debra J Tompson, Mark Whitaker, Rennan Pan
Pageof 1
Frequent Collaborators
2 joint publications
Marcy Powell
2 joint publications
Simon Hawkins
2 joint publications
Litza McKenzie
2 joint publications
Teresa Fuller
2 joint publications
Debra Tompson
2 joint publications
Mark Whitaker
2 joint publications
Rennan Pan
2 joint publications
Geoffrey Johnson
1 joint publications
Jamie Rees
1 joint publications
Sarah Siederer
